Skip to content

Clinical trials

Insulin Resistance trials in Singapore with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Not applicable Country / region: Singapore Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20171
20192
20201
20212
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University of Singapore4
Institute for Human Development and Potential (IHDP), Singapore3
Singapore Institute of Food and Biotechnology Innovation3
Singapore General Hospital2
KK Women's and Children's Hospital1
Nanyang Technological University1
National University Hospital, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance15
Diabetes Mellitus, Type 22
Glucose Intolerance2
Obesity2
Diabetes Mellitus1
Glucose Metabolism Disorders1
Hyperglycemia1
Metabolic Diseases1
Obesity, Abdominal1
Obesity, Morbid1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.